Fractyl Health (GUTS) - Pendapatan perusahaan

Fractyl Health, Inc. (GUTS) is developing innovative endoscopic and gene therapies to combat obesity and diabetes. The company's sales time series on GURU.Markets reflects current demand, where the 0.00 mark captures this metric. The business is shielded from macroeconomic shocks due to the specific nature of medicine, although financial stability currently relies entirely on external research investments.

GUTS Fractyl Health, Inc: Pendapatan perusahaan ing interval 21.02.2024 - 15.11.2026

Rincian analitis perusahaan Fractyl Health, Inc.

- rega lan prakiraan konsensus rega:

Rega saham Fractyl Health, Inc.|GUTS - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Nilai pasar Fractyl|GUTS - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Aset Bersih saben Saham Fractyl Health|GUTS - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku fractyl.com|GUTS - Total Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Koefisien Total Utang marang Modal Fractyl Health, Inc.|GUTS - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Fractyl Health, Inc|GUTS - Utang perusahaan|Utang marang nilai buku Fractyl Health Inc.|GUTS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Fractyl Health|Rasio jangkoan perantara fractyl.com

- data bathi bisnis lan rasio investasi:

GUTS - Bathi resik|Proyeksi bathi mangsa ngarep Fractyl Health, Inc.|GUTS - Pangali P/E|Prakiraan rega marang bathi Fractyl|GUTS - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Fractyl Health, Inc|GUTS - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Fractyl Health|GUTS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan fractyl.com|GUTS - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Fractyl Health, Inc.

- indikator volume dodolan lan pendapatan:

GUTS - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Fractyl Health, Inc.|GUTS - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Fractyl Health Inc.

Analisis komprehensif perusahaan:GUTS Fractyl Health, Inc.

Investors seek an equilibrium point between an asset's market value and its intrinsic quality. This indicator aggregates daily sales revenue, allowing for an assessment of the business's real operational efficiency relative to historical values. For Fractyl Health, Inc. (GUTS), this reflects the commercial success of implementing innovative therapies for diabetes and obesity. By analyzing the company's current sales volume, one can determine the resilience of its fundamental metrics against inflationary pressure.

Pesaing wigati